Attached files
file | filename |
---|---|
10-Q - CASI Pharmaceuticals, Inc. | v201299_10q.htm |
EX-10.2 - EX-10.2 - CASI Pharmaceuticals, Inc. | v201299_ex10-2.htm |
EX-31.1 - CASI Pharmaceuticals, Inc. | v201299_ex31-1.htm |
EX-31.2 - CASI Pharmaceuticals, Inc. | v201299_ex31-2.htm |
EX-32.2 - CASI Pharmaceuticals, Inc. | v201299_ex32-2.htm |
Exhibit
32.1
CERTIFICATION
BY EXECUTIVE CHAIRMAN
PURSUANT
TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of EntreMed, Inc. (the “Company”) on Form
10-Q for the period ending September 30, 2010 as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, Michael M. Tarnow, as
Executive Chairman of the Company, hereby certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to
the best of my knowledge, that:
|
(1)
|
The
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company
for the dates and periods covered by the
Report.
|
The
foregoing certification is being furnished solely pursuant to 18 U.S.C. Section
1350 and is not being filed as part of the Report or as a separate disclosure
document.
/s/ Michael M. Tarnow
|
|||
November
12, 2010
|
Michael
M. Tarnow
|
||
Executive
Chairman
|